Evidence map›Paper›PMID 34157075›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

Chronic Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in the Immunocompromised Patient: New Challenges and Urgent Needs.

Lorenzo Lodi, Maria Moriondo, Alessandra Pucci, Laura Pisano, Silvia Ricci, Giuseppe Indolfi, Chiara Azzari

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Spike protein of SARS-CoV-2 variants: a brief review and practical implications.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2022
    Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Lorenzo LodiDepartment of Health Sciences, University of Florence and Meyer Children's University Hospital, Florence, Italy.ORCID 0000-0001-6902-544X
Maria MoriondoImmunology and Molecular Microbiology Unit, Meyer Children's University Hospital, Florence, Italy.
Alessandra PucciDepartment of Health Sciences, University of Florence and Meyer Children's University Hospital, Florence, Italy.
Laura PisanoImmunology and Molecular Microbiology Unit, Meyer Children's University Hospital, Florence, Italy.
Silvia RicciDepartment of Health Sciences, University of Florence and Meyer Children's University Hospital, Florence, Italy.
Giuseppe IndolfiDepartment of Pediatrics, Meyer Children's University Hospital, Florence, Italy.
Chiara AzzariDepartment of Health Sciences, University of Florence and Meyer Children's University Hospital, Florence, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19SARS-CoV-2HumansImmunocompromised Host

Identifiers

PMID34157075

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.